LeonaBio Inc expected to post a loss of $1.26 a share - Earnings Preview
LeonaBio Inc <LONA.OQ> expected to post a loss of $1.26 a share - Earnings Preview
LeonaBio Inc LONA.OQ LONA.O is expected to show no change in quarterly revenue when it reports results on August 5 (estimated) for the period ending June 30 2026
LSEG's mean analyst estimate for LeonaBio Inc is for a loss of $1.26 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for LeonaBio Inc is $18.00, about 155% above its last closing price of $7.06
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | -2.51 | -2.50 | -1.73 | Beat | 30.8 |
Dec. 31 2026 | -1.38 | -1.28 | -3.46 | Missed | -171 |
Sep. 30 2025 | -1.22 | -1.22 | -1.68 | Missed | -37.7 |
Jun. 30 2025 | -1.80 | -1.80 | -1.80 | Met | 0 |
Mar. 31 2025 | -2.40 | -2.40 | -2.30 | Beat | 4.2 |
Dec. 31 2024 | -4.69 | -4.41 | -3.90 | Beat | 11.5 |
Sep. 30 2024 | -6.84 | -7.06 | -7.50 | Missed | -6.2 |
Jun. 30 2024 | -7.42 | -7.37 | -7.00 | Beat | 5 |
This summary was machine generated August 3 at 11:18 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)